Primecap Management
AZN icon

Primecap Management’s AstraZeneca AZN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.88B Buy
41,200,091
+538,606
+1% +$37.6M 2.28% 9
2025
Q1
$2.99B Sell
40,661,485
-358,042
-0.9% -$26.3M 2.47% 7
2024
Q4
$2.69B Sell
41,019,527
-960,518
-2% -$62.9M 2.08% 12
2024
Q3
$3.27B Sell
41,980,045
-617,190
-1% -$48.1M 2.4% 7
2024
Q2
$3.32B Sell
42,597,235
-347,940
-0.8% -$27.1M 2.41% 9
2024
Q1
$2.91B Sell
42,945,175
-41,900
-0.1% -$2.84M 2.17% 10
2023
Q4
$2.9B Sell
42,987,075
-902,290
-2% -$60.8M 2.29% 10
2023
Q3
$2.97B Sell
43,889,365
-187,935
-0.4% -$12.7M 2.51% 7
2023
Q2
$3.15B Sell
44,077,300
-1,312,557
-3% -$93.9M 2.64% 6
2023
Q1
$3.15B Buy
45,389,857
+403,017
+0.9% +$28M 2.75% 5
2022
Q4
$3.05B Sell
44,986,840
-627,270
-1% -$42.5M 2.79% 5
2022
Q3
$2.5B Sell
45,614,110
-199,710
-0.4% -$11M 2.42% 7
2022
Q2
$3.03B Sell
45,813,820
-504,060
-1% -$33.3M 2.71% 6
2022
Q1
$3.07B Sell
46,317,880
-372,620
-0.8% -$24.7M 2.32% 9
2021
Q4
$2.72B Sell
46,690,500
-1,575,750
-3% -$91.8M 1.88% 14
2021
Q3
$2.9B Sell
48,266,250
-437,943
-0.9% -$26.3M 2.05% 12
2021
Q2
$2.92B Sell
48,704,193
-1,209,033
-2% -$72.4M 1.96% 12
2021
Q1
$2.48B Sell
49,913,226
-195,720
-0.4% -$9.73M 1.73% 15
2020
Q4
$2.5B Sell
50,108,946
-1,389,115
-3% -$69.4M 1.86% 13
2020
Q3
$2.82B Sell
51,498,061
-2,163,676
-4% -$119M 2.33% 9
2020
Q2
$2.84B Sell
53,661,737
-2,979,584
-5% -$158M 2.44% 8
2020
Q1
$2.53B Sell
56,641,321
-2,141,045
-4% -$95.6M 2.48% 8
2019
Q4
$2.93B Sell
58,782,366
-46,830
-0.1% -$2.33M 2.13% 12
2019
Q3
$2.62B Buy
58,829,196
+785,065
+1% +$35M 2.1% 10
2019
Q2
$2.4B Buy
58,044,131
+1,700,975
+3% +$70.2M 1.77% 12
2019
Q1
$2.28B Buy
56,343,156
+195,230
+0.3% +$7.89M 1.68% 17
2018
Q4
$2.13B Buy
56,147,926
+748,640
+1% +$28.4M 1.73% 14
2018
Q3
$2.19B Buy
55,399,286
+2,364,013
+4% +$93.5M 1.48% 19
2018
Q2
$1.86B Buy
53,035,273
+1,469,835
+3% +$51.6M 1.38% 20
2018
Q1
$1.8B Buy
51,565,438
+5,552,804
+12% +$194M 1.35% 22
2017
Q4
$1.6B Buy
46,012,634
+2,577,104
+6% +$89.4M 1.23% 23
2017
Q3
$1.47B Buy
43,435,530
+5,535,180
+15% +$188M 1.22% 22
2017
Q2
$1.29B Buy
37,900,350
+3,589,400
+10% +$122M 1.11% 26
2017
Q1
$1.07B Buy
34,310,950
+8,330,675
+32% +$259M 0.97% 29
2016
Q4
$710M Buy
25,980,275
+8,666,950
+50% +$237M 0.7% 44
2016
Q3
$569M Buy
17,313,325
+1,947,375
+13% +$64M 0.57% 51
2016
Q2
$464M Buy
15,365,950
+2,281,675
+17% +$68.9M 0.49% 57
2016
Q1
$368M Buy
13,084,275
+12,095,375
+1,223% +$341M 0.38% 65
2015
Q4
$33.6M Buy
988,900
+805,000
+438% +$27.3M 0.03% 184
2015
Q3
$5.85M Buy
+183,900
New +$5.85M 0.01% 238